Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Sponsor: Kailera
Summary
The primary objective of this study is to determine the effects of ribupatide administered by subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.
Official title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2026-03-04
Completion Date
2027-06
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Interventions
Ribupatide
SC Injection
Placebo
SC Injection
Locations (35)
Kailera Clinical Site
Mesa, Arizona, United States
Kailera Clinical Site
Sun City West, Arizona, United States
Kailera Clinical Site
Irvine, California, United States
Kailera Clinical Site
Lake Forest, California, United States
Kailera Clinical Site
Lomita, California, United States
Kailera Clinical Site
Long Beach, California, United States
Kailera Clinical Site
Montclair, California, United States
Kailera Clinical Site
Rolling Hills Estates, California, United States
Kailera Clinical Site
San Diego, California, United States
Kailera Clinical Site
Santa Ana, California, United States
Kailera Clinical Site
Van Nuys, California, United States
Kailera Clinical Site
DeLand, Florida, United States
Kailera Clinical Site
Orlando, Florida, United States
Kailera Clinical Site
Orlando, Florida, United States
Kailera Clinical Site
The Villages, Florida, United States
Kailera Clinical Site
Decatur, Georgia, United States
Kailera Clinical Site
Woodstock, Georgia, United States
Kailera Clinical Site
Morton, Illinois, United States
Kailera Clinical Site
Indianapolis, Indiana, United States
Kailera Clinical Site
Louisville, Kentucky, United States
Kailera Clinical Site
Rockville, Maryland, United States
Kailera Clinical Site
St Louis, Missouri, United States
Kailera Clinical Site
Lincoln, Nebraska, United States
Kailera Clinical Site
Omaha, Nebraska, United States
Kailera Clinical Site
East Syracuse, New York, United States
Kailera Clinical Site
Greensboro, North Carolina, United States
Kailera Clinical Site
Monroe, North Carolina, United States
Kailera Clinical Site
Raleigh, North Carolina, United States
Kailera Clinical Site
Greenville, South Carolina, United States
Kailera Clinical Site
Myrtle Beach, South Carolina, United States
Kailera Clinical Site
Knoxville, Tennessee, United States
Kailera Clinical Site
Memphis, Tennessee, United States
Kailera Clinical Site
Garland, Texas, United States
Kailera Clinical Site
San Antonio, Texas, United States
Kailera Clinical Site
Winchester, Virginia, United States